1. Home
  2. SNDX vs FCF Comparison

SNDX vs FCF Comparison

Compare SNDX & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • FCF
  • Stock Information
  • Founded
  • SNDX 2005
  • FCF 1934
  • Country
  • SNDX United States
  • FCF United States
  • Employees
  • SNDX N/A
  • FCF N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • FCF Major Banks
  • Sector
  • SNDX Health Care
  • FCF Finance
  • Exchange
  • SNDX Nasdaq
  • FCF Nasdaq
  • Market Cap
  • SNDX 1.6B
  • FCF 1.7B
  • IPO Year
  • SNDX 2016
  • FCF N/A
  • Fundamental
  • Price
  • SNDX $15.83
  • FCF $18.74
  • Analyst Decision
  • SNDX Strong Buy
  • FCF Hold
  • Analyst Count
  • SNDX 11
  • FCF 5
  • Target Price
  • SNDX $36.00
  • FCF $17.30
  • AVG Volume (30 Days)
  • SNDX 1.7M
  • FCF 580.5K
  • Earning Date
  • SNDX 11-05-2024
  • FCF 10-29-2024
  • Dividend Yield
  • SNDX N/A
  • FCF 2.77%
  • EPS Growth
  • SNDX N/A
  • FCF N/A
  • EPS
  • SNDX N/A
  • FCF 1.48
  • Revenue
  • SNDX $16,000,000.00
  • FCF $456,467,000.00
  • Revenue This Year
  • SNDX N/A
  • FCF N/A
  • Revenue Next Year
  • SNDX $219.92
  • FCF $2.15
  • P/E Ratio
  • SNDX N/A
  • FCF $12.67
  • Revenue Growth
  • SNDX N/A
  • FCF 1.76
  • 52 Week Low
  • SNDX $14.81
  • FCF $12.41
  • 52 Week High
  • SNDX $25.34
  • FCF $19.51
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 32.96
  • FCF 61.36
  • Support Level
  • SNDX $16.03
  • FCF $18.33
  • Resistance Level
  • SNDX $17.87
  • FCF $19.51
  • Average True Range (ATR)
  • SNDX 0.93
  • FCF 0.56
  • MACD
  • SNDX -0.45
  • FCF 0.16
  • Stochastic Oscillator
  • SNDX 1.26
  • FCF 77.42

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

Share on Social Networks: